Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...
News-Medical.Net on MSN
Why promising microbiome therapies rarely work in patients
Addressing the microbiome's translational gap involves understanding biological complexity and developing function-driven, patient-specific interventions.
Although the year brought a steady stream of new treatments, tests, and cutting-edge science, experts worry about how politics will impact innovation long term.
Stanford researchers have developed an AI that can predict future disease risk using data from just one night of sleep. The ...
A study has found that people exercise regularly, quit smoking, and practice five other health strategies can improve their chances of living longer after cancer.
Obtaining clearer functional MRI data about the brain and its disorders is possible using artificial intelligence, according ...
Adolescent and young adult cancer survivors age faster than their peers who did not have cancer, according to a new study, ...
Cancer remains a leading cause of morbidity and mortality in Kenya, with the healthcare system increasingly challenged by ...
News-Medical.Net on MSN
Parkinson’s disease may stem from iron starvation rather than iron overload
This perspective argues that Parkinson’s disease may involve functional iron deficiency, where bioavailable iron is limited despite normal or elevated total iron in the brain. The authors propose that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results